The 'Superbug': Imagining A World Without Effective Antibiotics

Friday, August 13, 2010

An article last week in the journal Lancet Infectious Diseases documented a new and dangerous gene that could allow any bacteria to become a superbug that's resistant to antibiotics and almost impossible to treat. 37 people in the U.K. have been identified as carrying bacteria with the gene, called NDM-1, after visiting India and other parts of Asia for medical tourism. Medical personnel are worried that a new strain of superbug may threaten health worldwide. Why are new bugs so resistant to antibiotics? And what might a world look like as superbugs grow stronger? 

We speak with Maryn McKenna, a journalist and the author of "Superbug: The Fatal Menace of MRSA." McKenna has also recently blogged about NDM-1, and says that in her interviews with doctors across the country, their greatest fear is the spectre of "untreatable infections."


Maryn McKenna

Comments [2]

George Meredith MD from Virginia Beach, VA

The CDC rarely points out that MRSA infections often are related to some (foreign body) implant. Silastic being one of the worst! Toxic Shock Syndrome (TSS).

Basic surgical principals. Irrigate wound at end of operation with strong penicillin solution. If infection occurs, usually on the third postoperative day, then, open wound widely. Change one inch plain Nu Gauze Packing Strips twice daily. Don't rely on some super antibiotic. Get back to basics!

High dose IV Aqueous Penicillin, 60 million units per day intravenously, was the drug of choice before the FDA removed it from the marketplace.

Those phony little Culture and Sensitivity (C&S) discs, Dr Fauci, give completely different sensitivity results when the concentration of penicillin is increased ten fold.

Search: George Meredith MD Comments for more information.

"The best government is the least government."

George Meredith MD
Virginia Beach

Sep. 07 2010 02:31 PM
Unpopular Opinion

We basically need to stop exporting the most advanced antibiotics and we need to not use some antibiotics except on an in-patient basis. That will reduce the possibility of resistance building up. Also, the Feds and any countries we do export to should have to pay for the development of these drugs or they aren't going to exist. A country doesn't pay, they don't get them. Poor countries are unlikely to be able to keep controls on the use of them anyway.

Aug. 15 2010 09:36 PM

Leave a Comment

Email addresses are required but never displayed.